Iloperidone

Generic name: Pronounced as (eye'' loe per' i done)
Brand names
  • Fanapt®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 07/15/2017

Studies have shown that older adults with dementia (a brain disorder that affects the ability to remember, think clearly, communicate, and perform daily activities and that may cause changes in mood and personality) who take antipsychotics (medications for mental illness) such as iloperidone have an increased risk of death during treatment. Older adults with dementia may also have a greater chance of having a stroke or mini-stroke during treatment.

Iloperidone is not approved by the Food and Drug Administration (FDA) for the treatment of behavior problems in older adults with dementia. Talk to the doctor who prescribed this medication if you, a family member, or someone you care for has dementia and is taking iloperidone. For more information visit the FDA website: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm149578.htm.

Iloperidone is used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Iloperidone is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.

Iloperidone comes as a tablet to take by mouth. It is usually taken with or without food twice a day. Take iloperidone at around the same times every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take iloperidone exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Your doctor will probably start you on a low dose of iloperidone and gradually increase your dose, not more often than once every day for the first 7 days. Your doctor will also need to start you on a low dose of iloperidone and gradually increase your dose if you do not take iloperidone for 3 days or longer at any time during your treatment.

Iloperidone may help control your symptoms but will not cure your condition. It may take up to 2 weeks or longer before iloperidone begins to control your symptoms. Continue to take iloperidone even if you feel well. Do not stop taking iloperidone without talking to your doctor.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking iloperidone,

  • tell your doctor and pharmacist if you have had a serious allergic reaction (difficulty breathing or swallowing or swelling of the face, lips, throat, tongue, hands, or feet) to iloperidone. Your doctor will probably tell you not to take iloperidone. Also tell your doctor if you are allergic to any other medications, or any of the ingredients in iloperidone tablets. Ask your pharmacist for a list of the ingredients.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: amiodarone (Cordarone, Pacerone); antidepressants; antifungal medications such as itraconazole (Sporanox) and ketoconazole (Nizoral); bupropion (Aplenzin, Wellbutrin, Zyban); chlorpromazine; clarithromycin (Biaxin); fluoxetine (Prozac, Sarafem); gatifloxacin (Tequin) (not available in the U.S.); certain HIV protease inhibitors such as indinavir (Crixivan), nelfinavir (Viracept), and ritonavir (Norvir, in Kaletra); levo-alpha-acetylmethadol (ORLAAM) (not available in the U.S.); methadone (Dolophine, Methadose); medications for mental illness, high blood pressure, or seizures; moxifloxacin (Avelox); nefazodone; paroxetine (Paxil, Pexeva); pentamidine (Nebupent, Pentam); procainamide; quinidine; sedatives; sleeping pills; sotalol (Betapace); thioridazine or tranquilizers. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • tell your doctor if you use or have ever used street drugs or have overused prescription medications, or have or have had thoughts about harming or killing yourself. Also tell your doctor if you or anyone in your family has or has ever had diabetes and if you have or have ever had prolonged QT interval (a rare heart problem that may cause irregular heartbeat, fainting, or sudden death), a slow or irregular heartbeat, a recent heart attack, heart failure, dyslipidemia (high cholesterol levels), a low level of potassium or magnesium in your blood, seizures, breast cancer, trouble keeping your balance, any condition that makes it difficult for you to swallow, or heart or liver disease. Also tell your doctor if you have a low level of white blood cells or if you have ever developed a low level of blood cells as a side effect of a medication that you took. Also tell your doctor if you have severe vomiting or diarrhea or become dehydrated at any time during your treatment.

  • tell your doctor if you are pregnant, especially if you are in the last few months of your pregnancy, or if you plan to become pregnant or are breastfeeding. If you become pregnant while taking iloperidone, call your doctor. Iloperidone may cause problems in newborns following delivery if it is taken during the last months of pregnancy.

  • you should know that iloperidone may affect your thinking, judgment, and ability to move. Do not drive a car or operate machinery until you know how this medication affects you.

  • ask your doctor about the safe use of alcoholic beverages while you are taking iloperidone. Alcohol can make the side effects from iloperidone worse.

  • you should know that you may experience hyperglycemia (increases in your blood sugar) while you are taking this medication, even if you do not already have diabetes. If you have schizophrenia, you are more likely to develop diabetes than people who do not have schizophrenia, and taking iloperidone or similar medications may increase this risk. Tell your doctor immediately if you have any of the following symptoms while you are taking iloperidone: extreme thirst, frequent urination, extreme hunger, blurred vision, or weakness. It is very important to call your doctor as soon as you have any of these symptoms, because high blood sugar that is not treated can cause a serious condition called ketoacidosis. Ketoacidosis may become life-threatening if it is not treated at an early stage. Symptoms of ketoacidosis include: dry mouth, nausea and vomiting, shortness of breath, breath that smells fruity, and decreased consciousness.

  • you should know that iloperidone may cause dizziness, lightheadedness, fast heartbeat, and fainting when you get up too quickly from a lying position. This is more common when you first start taking iloperidone or when your dose is increased. To avoid this problem, get out of bed slowly, resting your feet on the floor for a few minutes before standing up.

  • you should know that taking iloperidone may make it harder for your body to cool down if it gets very hot. Tell your doctor if you plan to do vigorous exercise or be exposed to extreme heat.

Talk to your doctor about eating grapefruit and drinking grapefruit juice while taking this medicine.

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Iloperidone may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • weight gain

    • nausea

    • diarrhea

    • stomach pain

    • dry mouth

    • sleepiness

    • breast enlargement or discharge

    • missed menstrual periods

    • decreased sexual ability in men

    • joint pain

    • dizziness, feeling unsteady, or having trouble keeping your balance

  • Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately:

    • rash

    • hives

    • itching

    • swelling of the face, lips, throat, tongue, hands, or feet

    • difficulty breathing or swallowing

    • dizziness; fast, pounding, or irregular heartbeat; or fainting

    • falling

    • unusual movements of the face or body that you cannot control

    • seizures

    • sore throat, fever, chills, and other signs of infection

    • unexplained fever without other signs of infection

    • muscle stiffness

    • confusion

    • sweating

    • painful erection that lasts for hours

  • Iloperidone may cause other side effects. Call your doctor if you have any unusual problems while you are taking this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include the following:

  • drowsiness

  • fast or irregular heartbeat

  • slow or abnormal movements

Keep all appointments with your doctor and the laboratory. Your doctor may order certain lab tests to check your body's response to iloperidone.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Moxifloxacin Moxifloxacin The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Iloperidone.
Repaglinide Repaglinide The therapeutic efficacy of Repaglinide can be decreased when used in combination with Iloperidone.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Iloperidone.
Delavirdine Delavirdine The metabolism of Iloperidone can be decreased when combined with Delavirdine.
Nevirapine Nevirapine The metabolism of Iloperidone can be decreased when combined with Nevirapine.
Atorvastatin Atorvastatin The metabolism of Iloperidone can be decreased when combined with Atorvastatin.
Dolasetron Dolasetron The risk or severity of QTc prolongation can be increased when Dolasetron is combined with Iloperidone.
Anagrelide Anagrelide The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Iloperidone.
Candesartan Candesartan Iloperidone may decrease the antihypertensive activities of Candesartan.
Cilostazol Cilostazol The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Iloperidone.
Clopidogrel Clopidogrel The metabolism of Iloperidone can be decreased when combined with Clopidogrel.
Diphenoxylate Diphenoxylate The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Iloperidone.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The metabolism of Iloperidone can be decreased when combined with Erythromycin.
Guanfacine Guanfacine The risk or severity of adverse effects can be increased when Guanfacine is combined with Iloperidone.
Methylergonovine Methylergonovine The metabolism of Iloperidone can be decreased when combined with Methylergometrine.
Miglitol Miglitol The therapeutic efficacy of Miglitol can be decreased when used in combination with Iloperidone.
Naratriptan Naratriptan The risk or severity of adverse effects can be increased when Naratriptan is combined with Iloperidone.
Olsalazine Olsalazine The risk or severity of hypertension can be increased when Olsalazine is combined with Iloperidone.
Paregoric Paregoric The risk or severity of adverse effects can be increased when Morphine is combined with Iloperidone.
Penbutolol Penbutolol The risk or severity of QTc prolongation can be increased when Acebutolol is combined with Iloperidone.
Pentazocine Pentazocine The risk or severity of adverse effects can be increased when Pentazocine is combined with Iloperidone.
Ranitidine Ranitidine The metabolism of Iloperidone can be decreased when combined with Ranitidine.
Reserpine Reserpine The risk or severity of adverse effects can be increased when Reserpine is combined with Iloperidone.
Rizatriptan Rizatriptan The risk or severity of adverse effects can be increased when Rizatriptan is combined with Iloperidone.
Sumatriptan Sumatriptan The risk or severity of adverse effects can be increased when Sumatriptan is combined with Iloperidone.
Tacrolimus Tacrolimus The metabolism of Iloperidone can be decreased when combined with Tacrolimus.
Tizanidine Tizanidine The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Iloperidone.
Triamcinolone Triamcinolone The metabolism of Iloperidone can be increased when combined with Triamcinolone.
Zolmitriptan Zolmitriptan The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Iloperidone.
Famotidine Injection Famotidine Injection The risk or severity of QTc prolongation can be increased when Famotidine is combined with Iloperidone.
Fluconazole Injection Fluconazole Injection The metabolism of Iloperidone can be decreased when combined with Fluconazole.
Foscarnet Injection Foscarnet Injection The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Iloperidone.
Hydromorphone Injection Hydromorphone Injection The risk or severity of adverse effects can be increased when Hydromorphone is combined with Iloperidone.
Levofloxacin Injection Levofloxacin Injection The risk or severity of QTc prolongation can be increased when Levofloxacin is combined with Iloperidone.
Meperidine Injection Meperidine Injection The risk or severity of adverse effects can be increased when Meperidine is combined with Iloperidone.
Metoclopramide Injection Metoclopramide Injection The risk or severity of adverse effects can be increased when Metoclopramide is combined with Iloperidone.
Metronidazole Injection Metronidazole Injection The metabolism of Iloperidone can be decreased when combined with Metronidazole.
Morphine Injection Morphine Injection The risk or severity of adverse effects can be increased when Morphine is combined with Iloperidone.
Altretamine Altretamine Amphetamine may decrease the sedative and stimulatory activities of Iloperidone.
Cyclosporine Cyclosporine The metabolism of Iloperidone can be decreased when combined with Cyclosporine.
Ondansetron Ondansetron The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Iloperidone.
Granisetron Granisetron The risk or severity of QTc prolongation can be increased when Granisetron is combined with Iloperidone.
Torsemide Torsemide Iloperidone may decrease the antihypertensive activities of Torasemide.
Olanzapine Olanzapine Iloperidone may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Olanzapine.
Alosetron Alosetron The risk or severity of adverse effects can be increased when Alosetron is combined with Iloperidone.
Dofetilide Dofetilide The risk or severity of QTc prolongation can be increased when Dofetilide is combined with Iloperidone.
Entacapone Entacapone The therapeutic efficacy of Entacapone can be decreased when used in combination with Iloperidone.
Eprosartan Eprosartan Iloperidone may decrease the antihypertensive activities of Eprosartan.
Hydroxychloroquine Hydroxychloroquine The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Iloperidone.
Meloxicam Meloxicam The risk or severity of hypertension can be increased when Meloxicam is combined with Iloperidone.
Oxcarbazepine Oxcarbazepine The metabolism of Iloperidone can be decreased when combined with Oxcarbazepine.
Telmisartan Telmisartan Iloperidone may decrease the antihypertensive activities of Telmisartan.
Zaleplon Zaleplon The risk or severity of adverse effects can be increased when Zaleplon is combined with Iloperidone.
Anakinra Anakinra The metabolism of Iloperidone can be increased when combined with Anakinra.
Desloratadine Desloratadine The risk or severity of QTc prolongation can be increased when Desloratadine is combined with Iloperidone.
Linezolid Linezolid The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Iloperidone.
Trimipramine Trimipramine Trimipramine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Iloperidone.
Etanercept Injection Etanercept Injection The metabolism of Iloperidone can be increased when combined with Etanercept.
Glycopyrrolate Glycopyrrolate Iloperidone may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.
Modafinil Modafinil The metabolism of Iloperidone can be increased when combined with Modafinil.
Perindopril Perindopril Iloperidone may decrease the antihypertensive activities of Perindopril.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate The risk or severity of hypertension can be increased when Choline magnesium trisalicylate is combined with Iloperidone.
Sirolimus Sirolimus The metabolism of Sirolimus can be decreased when combined with Iloperidone.
Dutasteride Dutasteride The metabolism of Iloperidone can be decreased when combined with Dutasteride.
Epinephrine Injection Epinephrine Injection The metabolism of Iloperidone can be decreased when combined with Epinephrine.
Eplerenone Eplerenone The metabolism of Iloperidone can be decreased when combined with Eplerenone.
Escitalopram Escitalopram The serum concentration of Iloperidone can be increased when it is combined with Escitalopram.
Olmesartan Olmesartan Iloperidone may decrease the antihypertensive activities of Olmesartan.
Zonisamide Zonisamide The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Iloperidone.
Adalimumab Injection Adalimumab Injection The metabolism of Iloperidone can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole Aripiprazole may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Iloperidone.
Atomoxetine Atomoxetine The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Iloperidone.
Dexmethylphenidate Dexmethylphenidate The risk or severity of adverse effects can be increased when Iloperidone is combined with Dexmethylphenidate.
Atazanavir Atazanavir The metabolism of Iloperidone can be decreased when combined with Atazanavir.
Almotriptan Almotriptan The risk or severity of adverse effects can be increased when Almotriptan is combined with Iloperidone.
Eletriptan Eletriptan The risk or severity of adverse effects can be increased when Eletriptan is combined with Iloperidone.
Mefloquine Mefloquine The metabolism of Iloperidone can be decreased when combined with Mefloquine.
Rosuvastatin Rosuvastatin The metabolism of Iloperidone can be decreased when combined with Rosuvastatin.
Vardenafil Vardenafil The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Iloperidone.
Alfuzosin Alfuzosin Alfuzosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Iloperidone.
Aprepitant Aprepitant The metabolism of Iloperidone can be decreased when combined with Aprepitant.
Memantine Memantine The therapeutic efficacy of Memantine can be decreased when used in combination with Iloperidone.
Tegaserod Tegaserod The metabolism of Iloperidone can be decreased when combined with Tegaserod.
Tadalafil Tadalafil The risk or severity of hypotension, dyspepsia, and headache can be increased when Tadalafil is combined with Iloperidone.
Frovatriptan Frovatriptan The risk or severity of adverse effects can be increased when Frovatriptan is combined with Iloperidone.
Gemifloxacin Gemifloxacin The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Iloperidone.
Progesterone Progesterone The metabolism of Iloperidone can be decreased when combined with Progesterone.
Apomorphine Injection Apomorphine Injection The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Iloperidone.
Infliximab Injection Infliximab Injection The metabolism of Iloperidone can be increased when combined with Infliximab.
Protriptyline Protriptyline The risk or severity of adverse effects can be increased when Protriptyline is combined with Iloperidone.
Duloxetine Duloxetine The metabolism of Iloperidone can be decreased when combined with Duloxetine.
Norethindrone Norethindrone The metabolism of Iloperidone can be decreased when combined with Norethisterone.
Trospium Trospium Iloperidone may increase the central nervous system depressant (CNS depressant) activities of Trospium.
Bosentan Bosentan Iloperidone may decrease the antihypertensive activities of Bosentan.
Cinacalcet Cinacalcet The metabolism of Iloperidone can be decreased when combined with Cinacalcet.
Erlotinib Erlotinib The metabolism of Iloperidone can be decreased when combined with Erlotinib.
Eszopiclone Eszopiclone The risk or severity of CNS depression can be increased when Iloperidone is combined with Eszopiclone.
Insulin Aspart (rDNA Origin) Injection Insulin Aspart (rDNA Origin) Injection The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Iloperidone.
Solifenacin Solifenacin The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Iloperidone.
Voriconazole Voriconazole The metabolism of Iloperidone can be decreased when combined with Voriconazole.
Dextroamphetamine Dextroamphetamine Amphetamine may decrease the sedative and stimulatory activities of Iloperidone.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The metabolism of Iloperidone can be decreased when combined with Peginterferon alfa-2b.
Pramlintide Injection Pramlintide Injection The therapeutic efficacy of Pramlintide can be decreased when used in combination with Iloperidone.
Sodium Oxybate Sodium Oxybate Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Iloperidone.
Exenatide Injection Exenatide Injection The therapeutic efficacy of Exenatide can be decreased when used in combination with Iloperidone.
Ibandronate Ibandronate The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Iloperidone.
Isocarboxazid Isocarboxazid The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Iloperidone.
Ramelteon Ramelteon The risk or severity of adverse effects can be increased when Ramelteon is combined with Iloperidone.
Darifenacin Darifenacin The metabolism of Darifenacin can be decreased when combined with Iloperidone.
Fentanyl Fentanyl The risk or severity of adverse effects can be increased when Fentanyl is combined with Iloperidone.
Pregabalin Pregabalin The therapeutic efficacy of Iloperidone can be increased when used in combination with Pregabalin.
Phenylephrine Phenylephrine The therapeutic efficacy of Phenylephrine can be decreased when used in combination with Iloperidone.
Tipranavir Tipranavir The metabolism of Iloperidone can be decreased when combined with Tipranavir.
Felbamate Felbamate The risk or severity of QTc prolongation can be increased when Felbamate is combined with Iloperidone.
Insulin Detemir (rDNA Origin) Injection Insulin Detemir (rDNA Origin) Injection The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Iloperidone.
Ranolazine Ranolazine The metabolism of Iloperidone can be decreased when combined with Ranolazine.
Abatacept Injection Abatacept Injection The metabolism of Iloperidone can be increased when combined with Abatacept.
Rasagiline Rasagiline The therapeutic efficacy of Rasagiline can be decreased when used in combination with Iloperidone.
Imatinib Imatinib The metabolism of Iloperidone can be decreased when combined with Imatinib.
Sitagliptin Sitagliptin The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Iloperidone.
Gefitinib Gefitinib The metabolism of Iloperidone can be decreased when combined with Gefitinib.
Albuterol Albuterol The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Iloperidone.
Paliperidone Paliperidone Paliperidone may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Iloperidone.
Bortezomib Bortezomib The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Iloperidone.
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Iloperidone.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Iloperidone.
Posaconazole Posaconazole The metabolism of Iloperidone can be decreased when combined with Posaconazole.
Primaquine Primaquine The metabolism of Iloperidone can be decreased when combined with Primaquine.
Aliskiren Aliskiren Iloperidone may decrease the antihypertensive activities of Aliskiren.
Bismuth Subsalicylate Bismuth Subsalicylate Bismuth subsalicylate may increase the neurotoxic activities of Iloperidone.
Darunavir Darunavir The metabolism of Iloperidone can be decreased when combined with Darunavir.
Dimenhydrinate Dimenhydrinate The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Iloperidone.
Lisdexamfetamine Lisdexamfetamine Lisdexamfetamine may decrease the sedative and stimulatory activities of Iloperidone.
Nabilone Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Iloperidone.
Vorinostat Vorinostat The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Iloperidone.
Sorafenib Sorafenib The metabolism of Iloperidone can be decreased when combined with Sorafenib.
Sunitinib Sunitinib The metabolism of Iloperidone can be decreased when combined with Sunitinib.
Dronabinol Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Iloperidone.
Lapatinib Lapatinib The metabolism of Iloperidone can be decreased when combined with Lapatinib.
Levocetirizine Levocetirizine The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Iloperidone.
Dasatinib Dasatinib The metabolism of Iloperidone can be decreased when combined with Dasatinib.
Mexiletine Mexiletine The metabolism of Iloperidone can be decreased when combined with Mexiletine.
Armodafinil Armodafinil The metabolism of Iloperidone can be increased when combined with Armodafinil.
Temsirolimus Temsirolimus The metabolism of Temsirolimus can be decreased when combined with Iloperidone.
Nilotinib Nilotinib The metabolism of Iloperidone can be decreased when combined with Nilotinib.
Toremifene Toremifene The risk or severity of QTc prolongation can be increased when Toremifene is combined with Iloperidone.
Budesonide Budesonide The metabolism of Iloperidone can be increased when combined with Budesonide.
Chloramphenicol Injection Chloramphenicol Injection The metabolism of Iloperidone can be decreased when combined with Chloramphenicol.
Desmopressin Desmopressin The risk or severity of hypertension can be increased when Desmopressin is combined with Iloperidone.
OnabotulinumtoxinA Injection OnabotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Iloperidone.
RimabotulinumtoxinB Injection RimabotulinumtoxinB Injection The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Iloperidone.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Iloperidone.
Mitoxantrone Injection Mitoxantrone Injection The metabolism of Iloperidone can be decreased when combined with Mitoxantrone.
Desvenlafaxine Desvenlafaxine The metabolism of Iloperidone can be decreased when combined with Desvenlafaxine.
Cevimeline Cevimeline The metabolism of Iloperidone can be decreased when combined with Cevimeline.
Nebivolol Nebivolol Nebivolol may increase the orthostatic hypotensive activities of Iloperidone.
Tretinoin Tretinoin The metabolism of Iloperidone can be decreased when combined with Tretinoin.
Pilocarpine Pilocarpine The metabolism of Iloperidone can be decreased when combined with Pilocarpine.
Flecainide Flecainide The metabolism of Flecainide can be decreased when combined with Iloperidone.
Certolizumab Injection Certolizumab Injection The metabolism of Iloperidone can be increased when combined with Certolizumab pegol.
Irinotecan Injection Irinotecan Injection The metabolism of Iloperidone can be decreased when combined with Irinotecan.
Praziquantel Praziquantel The metabolism of Iloperidone can be decreased when combined with Praziquantel.
Rufinamide Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Iloperidone.
Silodosin Silodosin Iloperidone may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Silodosin.
Midazolam Midazolam The metabolism of Iloperidone can be decreased when combined with Midazolam.
Naltrexone Injection Naltrexone Injection The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Iloperidone.
Milnacipran Milnacipran The metabolism of Iloperidone can be decreased when combined with Milnacipran.
Fesoterodine Fesoterodine Iloperidone may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.
Degarelix Injection Degarelix Injection The risk or severity of QTc prolongation can be increased when Degarelix is combined with Iloperidone.
Betaxolol Betaxolol The risk or severity of QTc prolongation can be increased when Betaxolol is combined with Iloperidone.
Lacosamide Lacosamide The risk or severity of adverse effects can be increased when Iloperidone is combined with Lacosamide.
Everolimus Everolimus The metabolism of Everolimus can be decreased when combined with Iloperidone.
Dronedarone Dronedarone Dronedarone may increase the QTc-prolonging activities of Iloperidone.
AbobotulinumtoxinA Injection AbobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Iloperidone.
Palonosetron Injection Palonosetron Injection The risk or severity of adverse effects can be increased when Palonosetron is combined with Iloperidone.
Saxagliptin Saxagliptin The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Iloperidone.
Telavancin Injection Telavancin Injection The risk or severity of QTc prolongation can be increased when Telavancin is combined with Iloperidone.
Romidepsin Injection Romidepsin Injection The risk or severity of QTc prolongation can be increased when Iloperidone is combined with Romidepsin.
Tapentadol Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Iloperidone.
Topotecan Topotecan The metabolism of Iloperidone can be decreased when combined with Topotecan.
Golimumab Injection Golimumab Injection The metabolism of Iloperidone can be increased when combined with Golimumab.
Pazopanib Pazopanib The metabolism of Iloperidone can be decreased when combined with Pazopanib.
Asenapine Asenapine Iloperidone may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Asenapine.
Vigabatrin Vigabatrin The risk or severity of adverse effects can be increased when Vigabatrin is combined with Iloperidone.
Levonorgestrel Levonorgestrel The metabolism of Iloperidone can be decreased when combined with Levonorgestrel.
Oxymorphone Oxymorphone The risk or severity of adverse effects can be increased when Oxymorphone is combined with Iloperidone.
Liraglutide Injection Liraglutide Injection The therapeutic efficacy of Liraglutide can be decreased when used in combination with Iloperidone.
Tocilizumab Injection Tocilizumab Injection The metabolism of Iloperidone can be increased when combined with Tocilizumab.
Eribulin Injection Eribulin Injection The risk or severity of QTc prolongation can be increased when Eribulin is combined with Iloperidone.
IncobotulinumtoxinA Injection IncobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Iloperidone.
Cabazitaxel Injection Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Iloperidone.
Lurasidone Lurasidone Iloperidone may increase the hypotensive activities of Lurasidone.
Acetaminophen Injection Acetaminophen Injection The metabolism of Iloperidone can be decreased when combined with Acetaminophen.
Vilazodone Vilazodone The metabolism of Vilazodone can be decreased when combined with Iloperidone.
Denileukin Diftitox Injection Denileukin Diftitox Injection The metabolism of Iloperidone can be decreased when combined with Aldesleukin.
Terbutaline Injection Terbutaline Injection The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Iloperidone.
Linagliptin Linagliptin The metabolism of Iloperidone can be decreased when combined with Linagliptin.
Rilpivirine Rilpivirine The metabolism of Iloperidone can be decreased when combined with Rilpivirine.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Iloperidone can be decreased when combined with Cyclophosphamide.
Abiraterone Abiraterone The metabolism of Iloperidone can be decreased when combined with Abiraterone.
Triptorelin Injection Triptorelin Injection The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Iloperidone.
Rivaroxaban Rivaroxaban The metabolism of Rivaroxaban can be decreased when combined with Iloperidone.
Ticagrelor Ticagrelor The metabolism of Iloperidone can be decreased when combined with Ticagrelor.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The metabolism of Iloperidone can be decreased when combined with Brentuximab vedotin.
Vandetanib Vandetanib The risk or severity of QTc prolongation can be increased when Iloperidone is combined with Vandetanib.
Clobazam Clobazam The metabolism of Iloperidone can be decreased when combined with Clobazam.
Vemurafenib Vemurafenib The risk or severity of QTc prolongation can be increased when Iloperidone is combined with Vemurafenib.
Ivacaftor Ivacaftor The metabolism of Iloperidone can be decreased when combined with Ivacaftor.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Iloperidone.
Crizotinib Crizotinib The metabolism of Iloperidone can be decreased when combined with Crizotinib.
Cabergoline Cabergoline The metabolism of Iloperidone can be decreased when combined with Cabergoline.
Naloxone Injection Naloxone Injection The metabolism of Iloperidone can be decreased when combined with Naloxone.
Ambrisentan Ambrisentan The metabolism of Ambrisentan can be decreased when combined with Iloperidone.
Ezogabine Ezogabine The risk or severity of adverse effects can be increased when Tiagabine is combined with Iloperidone.
Enzalutamide Enzalutamide The metabolism of Enzalutamide can be decreased when combined with Iloperidone.
Mirabegron Mirabegron The metabolism of Iloperidone can be decreased when combined with Mirabegron.
Regorafenib Regorafenib The metabolism of Iloperidone can be decreased when combined with Regorafenib.
Bosutinib Bosutinib The metabolism of Iloperidone can be decreased when combined with Bosutinib.
Lorcaserin Lorcaserin The therapeutic efficacy of Mecasermin can be decreased when used in combination with Iloperidone.
Bedaquiline Bedaquiline The risk or severity of QTc prolongation can be increased when Bedaquiline is combined with Iloperidone.
Alogliptin Alogliptin The therapeutic efficacy of Alogliptin can be decreased when used in combination with Iloperidone.
Ponatinib Ponatinib The metabolism of Ponatinib can be decreased when combined with Iloperidone.
Pomalidomide Pomalidomide The risk or severity of adverse effects can be increased when Iloperidone is combined with Pomalidomide.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The metabolism of Iloperidone can be decreased when combined with Trastuzumab emtansine.
Apixaban Apixaban The metabolism of Apixaban can be decreased when combined with Iloperidone.
Canagliflozin Canagliflozin The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Iloperidone.
Dabrafenib Dabrafenib The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Iloperidone.
Ospemifene Ospemifene The metabolism of Iloperidone can be decreased when combined with Ospemifene.
Levomilnacipran Levomilnacipran The risk or severity of adverse effects can be increased when Iloperidone is combined with Levomilnacipran.
Vortioxetine Vortioxetine The risk or severity of adverse effects can be increased when Iloperidone is combined with Vortioxetine.
Perampanel Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Iloperidone.
Ibrutinib Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Iloperidone.
Lomitapide Lomitapide The metabolism of Iloperidone can be decreased when combined with Lomitapide.
Avanafil Avanafil The risk or severity of hypotension, dyspepsia, and headache can be increased when Avanafil is combined with Iloperidone.
Ketorolac Injection Ketorolac Injection The risk or severity of hypertension can be increased when Ketorolac is combined with Iloperidone.
Simeprevir Simeprevir The metabolism of Iloperidone can be decreased when combined with Simeprevir.
Dapagliflozin Dapagliflozin The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Iloperidone.
Apremilast Apremilast The metabolism of Iloperidone can be increased when combined with Apremilast.
Droxidopa Droxidopa The therapeutic efficacy of Droxidopa can be decreased when used in combination with Iloperidone.
Ceritinib Ceritinib The metabolism of Iloperidone can be decreased when combined with Ceritinib.
Siltuximab Injection Siltuximab Injection The metabolism of Iloperidone can be decreased when combined with Siltuximab.
Albiglutide Injection Albiglutide Injection The therapeutic efficacy of Albiglutide can be decreased when used in combination with Iloperidone.
Eslicarbazepine Eslicarbazepine The risk or severity of adverse effects can be increased when Iloperidone is combined with Eslicarbazepine.
Idelalisib Idelalisib The metabolism of Iloperidone can be decreased when combined with Idelalisib.
Testosterone Injection Testosterone Injection The metabolism of Iloperidone can be decreased when combined with Testosterone.
Oritavancin Injection Oritavancin Injection The metabolism of Iloperidone can be decreased when combined with Oritavancin.
Empagliflozin Empagliflozin The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Iloperidone.
Hydrocodone Hydrocodone Hydrocodone may increase the central nervous system depressant (CNS depressant) activities of Iloperidone.
Suvorexant Suvorexant Iloperidone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Dulaglutide Injection Dulaglutide Injection The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Iloperidone.
Olaparib Olaparib The metabolism of Iloperidone can be decreased when combined with Olaparib.
Methamphetamine Methamphetamine Metamfetamine may decrease the sedative and stimulatory activities of Iloperidone.
Tasimelteon Tasimelteon The risk or severity of adverse effects can be increased when Iloperidone is combined with Tasimelteon.
Riociguat Riociguat Iloperidone may decrease the antihypertensive activities of Riociguat.
Lanreotide Injection Lanreotide Injection The metabolism of Iloperidone can be decreased when combined with Lanreotide.
Secukinumab Injection Secukinumab Injection The metabolism of Iloperidone can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection Risperidone may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Iloperidone.
Palbociclib Palbociclib The metabolism of Iloperidone can be decreased when combined with Palbociclib.
Insulin Human Inhalation Insulin Human Inhalation The therapeutic efficacy of Insulin human can be decreased when used in combination with Iloperidone.
Lenvatinib Lenvatinib The metabolism of Iloperidone can be decreased when combined with Lenvatinib.
Naloxegol Naloxegol The metabolism of Iloperidone can be decreased when combined with Naloxegol.
Panobinostat Panobinostat The metabolism of Iloperidone can be decreased when combined with Panobinostat.
Haloperidol Injection Haloperidol Injection The metabolism of Iloperidone can be decreased when combined with Haloperidol.
Ivabradine Ivabradine The risk or severity of QTc prolongation can be increased when Iloperidone is combined with Ivabradine.
Isavuconazonium Injection Isavuconazonium Injection The metabolism of Iloperidone can be decreased when combined with Isavuconazonium.
Macitentan Macitentan Iloperidone may decrease the antihypertensive activities of Macitentan.
Flibanserin Flibanserin The risk or severity of adverse effects can be increased when Flibanserin is combined with Iloperidone.
Rolapitant Rolapitant The metabolism of Iloperidone can be decreased when combined with Rolapitant.
Daclatasvir Daclatasvir The metabolism of Daclatasvir can be decreased when combined with Iloperidone.
Brexpiprazole Brexpiprazole Iloperidone may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Brexpiprazole.
Ziprasidone Injection Ziprasidone Injection The risk or severity of QTc prolongation can be increased when Ziprasidone is combined with Iloperidone.
Cariprazine Cariprazine The risk or severity of adverse effects can be increased when Iloperidone is combined with Cariprazine.
Eluxadoline Eluxadoline The risk or severity of serotonin syndrome can be increased when Iloperidone is combined with Eluxadoline.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection The therapeutic efficacy of Insulin degludec can be decreased when used in combination with Iloperidone.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Iloperidone.
Osimertinib Osimertinib The metabolism of Iloperidone can be decreased when combined with Osimertinib.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection The metabolism of Iloperidone can be decreased when combined with Amphotericin B.
Dexamethasone Injection Dexamethasone Injection The metabolism of Iloperidone can be decreased when combined with Dexamethasone.
Brivaracetam Injection Brivaracetam Injection The risk or severity of adverse effects can be increased when Iloperidone is combined with Brivaracetam.
Venetoclax Venetoclax The metabolism of Iloperidone can be decreased when combined with Venetoclax.
Cobicistat Cobicistat The metabolism of Iloperidone can be decreased when combined with Cobicistat.
Midodrine Midodrine The therapeutic efficacy of Midodrine can be decreased when used in combination with Iloperidone.
Selexipag Selexipag Iloperidone may decrease the antihypertensive activities of Selexipag.
Pimavanserin Pimavanserin The risk or severity of adverse effects can be increased when Iloperidone is combined with Pimavanserin.
Diphenhydramine Injection Diphenhydramine Injection The risk or severity of QTc prolongation can be increased when Diphenhydramine is combined with Iloperidone.
Furosemide Injection Furosemide Injection Iloperidone may decrease the antihypertensive activities of Furosemide.
Rucaparib Rucaparib The metabolism of Iloperidone can be decreased when combined with Rucaparib.
Lixisenatide Injection Lixisenatide Injection The therapeutic efficacy of Lixisenatide can be decreased when used in combination with Iloperidone.
Ribociclib Ribociclib The metabolism of Iloperidone can be decreased when combined with Ribociclib.
Doxepin (Insomnia) Doxepin (Insomnia) Iloperidone may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Doxepin.
Deutetrabenazine Deutetrabenazine The risk or severity of adverse effects can be increased when Iloperidone is combined with Deutetrabenazine.
Valbenazine Valbenazine The metabolism of Valbenazine can be decreased when combined with Iloperidone.
Deflazacort Deflazacort The metabolism of Iloperidone can be increased when combined with Deflazacort.
Safinamide Safinamide The therapeutic efficacy of Safinamide can be decreased when used in combination with Iloperidone.
Sarilumab Injection Sarilumab Injection The metabolism of Iloperidone can be decreased when combined with Sarilumab.
Midostaurin Midostaurin The metabolism of Iloperidone can be decreased when combined with Midostaurin.
Enasidenib Enasidenib The metabolism of Iloperidone can be decreased when combined with Enasidenib.
Aprepitant/Fosaprepitant Injection Aprepitant/Fosaprepitant Injection The metabolism of Iloperidone can be decreased when combined with Fosaprepitant.
Copanlisib Injection Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Iloperidone.
Delafloxacin Delafloxacin The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Iloperidone.
Acalabrutinib Acalabrutinib The metabolism of Iloperidone can be decreased when combined with Acalabrutinib.
Letermovir Letermovir The metabolism of Iloperidone can be decreased when combined with Letermovir.
Semaglutide Injection Semaglutide Injection The therapeutic efficacy of Semaglutide can be decreased when used in combination with Iloperidone.
Tetrabenazine Tetrabenazine The risk or severity of adverse effects can be increased when Iloperidone is combined with Tetrabenazine.
Ertugliflozin Ertugliflozin The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Iloperidone.
Buprenorphine Injection Buprenorphine Injection Iloperidone may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Fostamatinib Fostamatinib The metabolism of Iloperidone can be decreased when combined with Fostamatinib.
Lofexidine Lofexidine The therapeutic efficacy of Iloperidone can be increased when used in combination with Lofexidine.
Eliglustat Eliglustat The risk or severity of QTc prolongation can be increased when Eliglustat is combined with Iloperidone.
Encorafenib Encorafenib The risk or severity of QTc prolongation can be increased when Iloperidone is combined with Encorafenib.
Ivosidenib Ivosidenib The risk or severity of QTc prolongation can be increased when Ivosidenib is combined with Iloperidone.
Elagolix Elagolix The metabolism of Elagolix can be decreased when combined with Iloperidone.
Doravirine Doravirine The metabolism of Doravirine can be decreased when combined with Iloperidone.
Tafenoquine Tafenoquine The metabolism of Tafenoquine can be decreased when combined with Iloperidone.
Cannabidiol Cannabidiol The risk or severity of adverse effects can be increased when Cannabidiol is combined with Iloperidone.
Dacomitinib Dacomitinib The metabolism of Iloperidone can be decreased when combined with Dacomitinib.
Stiripentol Stiripentol The metabolism of Iloperidone can be decreased when combined with Stiripentol.
Gilteritinib Gilteritinib The therapeutic efficacy of Iloperidone can be decreased when used in combination with Gilteritinib.
Glasdegib Glasdegib The risk or severity of QTc prolongation can be increased when Iloperidone is combined with Glasdegib.
Lorlatinib Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Iloperidone.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Iloperidone.
Rifamycin Rifamycin The metabolism of Iloperidone can be decreased when combined with Rifamycin.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Iloperidone can be increased when combined with Emapalumab.
Siponimod Siponimod The risk or severity of hypertension can be increased when Iloperidone is combined with Siponimod.
Alpelisib Alpelisib The metabolism of Iloperidone can be decreased when combined with Alpelisib.
Brexanolone Injection Brexanolone Injection The risk or severity of adverse effects can be increased when Iloperidone is combined with Brexanolone.
Solriamfetol Solriamfetol The risk or severity of hypertension can be increased when Solriamfetol is combined with Iloperidone.
Triclabendazole Triclabendazole The metabolism of Iloperidone can be decreased when combined with Triclabendazole.
Entrectinib Entrectinib The risk or severity of QTc prolongation can be increased when Iloperidone is combined with Entrectinib.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Iloperidone.
Pitolisant Pitolisant The therapeutic efficacy of Pitolisant can be decreased when used in combination with Iloperidone.
Fedratinib Fedratinib The metabolism of Iloperidone can be decreased when combined with Fedratinib.
Lefamulin Lefamulin Lefamulin may increase the QTc-prolonging activities of Iloperidone.
Phenytoin Injection Phenytoin Injection The metabolism of Iloperidone can be increased when combined with Phenytoin.
Fosphenytoin Injection Fosphenytoin Injection The risk or severity of adverse effects can be increased when Fosphenytoin is combined with Iloperidone.
Lumateperone Lumateperone The risk or severity of adverse effects can be increased when Iloperidone is combined with Lumateperone.
Lasmiditan Lasmiditan The risk or severity of serotonin syndrome can be increased when Iloperidone is combined with Lasmiditan.
Cenobamate Cenobamate The metabolism of Iloperidone can be decreased when combined with Cenobamate.
Selumetinib Selumetinib The metabolism of Selumetinib can be decreased when combined with Iloperidone.
Tucatinib Tucatinib The metabolism of Tucatinib can be decreased when combined with Iloperidone.
Remdesivir Injection Remdesivir Injection The metabolism of Iloperidone can be decreased when combined with Remdesivir.
Selpercatinib Selpercatinib The risk or severity of hypertension can be increased when Iloperidone is combined with Selpercatinib.
Lemborexant Lemborexant The risk or severity of adverse effects can be increased when Iloperidone is combined with Lemborexant.
Fenfluramine Fenfluramine The risk or severity of serotonin syndrome can be increased when Fenfluramine is combined with Iloperidone.
Fostemsavir Fostemsavir The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Iloperidone.
Octreotide Octreotide The metabolism of Iloperidone can be decreased when combined with Octreotide.
Pralsetinib Pralsetinib The metabolism of Iloperidone can be decreased when combined with Pralsetinib.
Opicapone Opicapone The therapeutic efficacy of Opicapone can be decreased when used in combination with Iloperidone.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Iloperidone can be decreased when it is combined with Satralizumab.
Naxitamab-gqgk Injection Naxitamab-gqgk Injection The risk or severity of hypertension can be increased when Iloperidone is combined with Naxitamab.
Relugolix Relugolix The risk or severity of QTc prolongation can be increased when Relugolix is combined with Iloperidone.
Viloxazine Viloxazine The risk or severity of adverse effects can be increased when Iloperidone is combined with Viloxazine.
Theophylline Theophylline The metabolism of Iloperidone can be decreased when combined with Theophylline.
Fenoprofen Fenoprofen The risk or severity of hypertension can be increased when Fenoprofen is combined with Iloperidone.
Indomethacin Indomethacin The risk or severity of hypertension can be increased when Indomethacin is combined with Iloperidone.
Mefenamic Acid Mefenamic Acid The risk or severity of hypertension can be increased when Mefenamic acid is combined with Iloperidone.
Naproxen Naproxen The risk or severity of hypertension can be increased when Naproxen is combined with Iloperidone.
Tolmetin Tolmetin The risk or severity of hypertension can be increased when Tolmetin is combined with Iloperidone.
Sulindac Sulindac The risk or severity of hypertension can be increased when Sulindac is combined with Iloperidone.
Trazodone Trazodone The risk or severity of QTc prolongation can be increased when Trazodone is combined with Iloperidone.
Hydroxyurea Hydroxyurea The metabolism of Iloperidone can be decreased when combined with Hydroxyurea.
Phenobarbital Phenobarbital The metabolism of Iloperidone can be increased when combined with Phenobarbital.
Metaxalone Metaxalone The risk or severity of adverse effects can be increased when Metaxalone is combined with Iloperidone.
Levorphanol Levorphanol The risk or severity of adverse effects can be increased when Levorphanol is combined with Iloperidone.
Primidone Primidone The risk or severity of adverse effects can be increased when Primidone is combined with Iloperidone.
Methsuximide Methsuximide The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Iloperidone.
Diethylpropion Diethylpropion Diethylpropion may decrease the sedative and stimulatory activities of Iloperidone.
Chlorpromazine Chlorpromazine Chlorpromazine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Iloperidone.
Diazepam Diazepam The metabolism of Iloperidone can be decreased when combined with Diazepam.
Oxazepam Oxazepam The risk or severity of adverse effects can be increased when Oxazepam is combined with Iloperidone.
Flurazepam Flurazepam The risk or severity of adverse effects can be increased when Flurazepam is combined with Iloperidone.
Clorazepate Clorazepate The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Iloperidone.
Lorazepam Lorazepam The risk or severity of adverse effects can be increased when Lorazepam is combined with Iloperidone.
Phenoxybenzamine Phenoxybenzamine Phenoxybenzamine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Iloperidone.
Amantadine Amantadine The risk or severity of QTc prolongation can be increased when Amantadine is combined with Iloperidone.
Codeine Codeine The risk or severity of adverse effects can be increased when Codeine is combined with Iloperidone.
Meprobamate Meprobamate The risk or severity of adverse effects can be increased when Meprobamate is combined with Iloperidone.
Chlordiazepoxide Chlordiazepoxide The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Iloperidone.
Bromocriptine Bromocriptine The metabolism of Iloperidone can be decreased when combined with Bromocriptine.
Metaproterenol Metaproterenol The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Iloperidone.
Tranylcypromine Tranylcypromine The metabolism of Iloperidone can be decreased when combined with Tranylcypromine.
Phenelzine Phenelzine The metabolism of Iloperidone can be decreased when combined with Phenelzine.
Procarbazine Procarbazine The risk or severity of adverse effects can be increased when Procarbazine is combined with Iloperidone.
Ergoloid Mesylates Ergoloid Mesylates The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Iloperidone.
Tetracycline Tetracycline The metabolism of Iloperidone can be decreased when combined with Tetracycline.
Minocycline Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Iloperidone.
Prochlorperazine Prochlorperazine The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Iloperidone.
Thioridazine Thioridazine The metabolism of Iloperidone can be decreased when combined with Thioridazine.
Trifluoperazine Trifluoperazine Trifluoperazine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Iloperidone.
Dapsone Dapsone The metabolism of Iloperidone can be decreased when combined with Dapsone.
Sulfadiazine Sulfadiazine The therapeutic efficacy of Sulfadiazine can be decreased when used in combination with Iloperidone.
Oxycodone Oxycodone The risk or severity of adverse effects can be increased when Oxycodone is combined with Iloperidone.
Methadone Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Iloperidone.
Oxybutynin Oxybutynin The metabolism of Iloperidone can be decreased when combined with Oxybutynin.
Benztropine Benztropine The risk or severity of adverse effects can be increased when Iloperidone is combined with Benzatropine.
Maprotiline Maprotiline The risk or severity of adverse effects can be increased when Maprotiline is combined with Iloperidone.
Ibuprofen Ibuprofen The risk or severity of hypertension can be increased when Ibuprofen is combined with Iloperidone.
Trihexyphenidyl Trihexyphenidyl The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Iloperidone.
Orphenadrine Orphenadrine The metabolism of Iloperidone can be decreased when combined with Orphenadrine.
Perphenazine Perphenazine The risk or severity of adverse effects can be increased when Perphenazine is combined with Iloperidone.
Fluphenazine Fluphenazine The risk or severity of adverse effects can be increased when Fluphenazine is combined with Iloperidone.
Phentermine Phentermine Phentermine may decrease the sedative and stimulatory activities of Iloperidone.
Methylphenidate Methylphenidate The risk or severity of adverse effects can be increased when Iloperidone is combined with Methylphenidate.
Amoxapine Amoxapine Iloperidone may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Amoxapine.
Sulfasalazine Sulfasalazine The risk or severity of hypertension can be increased when Sulfasalazine is combined with Iloperidone.
Hydrocortisone Hydrocortisone The metabolism of Iloperidone can be decreased when combined with Hydrocortisone.
Doxorubicin Doxorubicin The metabolism of Iloperidone can be decreased when combined with Doxorubicin.
Carbamazepine Carbamazepine The metabolism of Iloperidone can be decreased when combined with Carbamazepine.
Molindone Molindone The risk or severity of adverse effects can be increased when Molindone is combined with Iloperidone.
Methyldopa Methyldopa The therapeutic efficacy of Methyldopa can be decreased when used in combination with Iloperidone.
Clonidine Clonidine The risk or severity of sedation can be increased when Clonidine is combined with Iloperidone.
Prazosin Prazosin Prazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Iloperidone.
Hydralazine Hydralazine The metabolism of Iloperidone can be decreased when combined with Hydralazine.
Cimetidine Cimetidine The metabolism of Iloperidone can be decreased when combined with Cimetidine.
Warfarin Warfarin The risk or severity of adverse effects can be increased when Iloperidone is combined with Warfarin.
Clonazepam Clonazepam The risk or severity of adverse effects can be increased when Clonazepam is combined with Iloperidone.
Loperamide Loperamide The metabolism of Iloperidone can be decreased when combined with Loperamide.
Promethazine Promethazine The risk or severity of QTc prolongation can be increased when Promethazine is combined with Iloperidone.
Meclofenamate Meclofenamate The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Iloperidone.
Daunorubicin Daunorubicin The metabolism of Iloperidone can be decreased when combined with Daunorubicin.
Digoxin Digoxin The risk or severity of QTc prolongation can be increased when Digoxin is combined with Iloperidone.
Loxapine Loxapine The risk or severity of adverse effects can be increased when Loxapine is combined with Iloperidone.
Chloroquine Chloroquine The metabolism of Iloperidone can be decreased when combined with Chloroquine.
Quinine Quinine The metabolism of Iloperidone can be decreased when combined with Quinine.
Ethosuximide Ethosuximide The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Iloperidone.
Chlorothiazide Chlorothiazide Iloperidone may decrease the antihypertensive activities of Chlorothiazide.
Chlorthalidone Chlorthalidone Iloperidone may decrease the antihypertensive activities of Chlorthalidone.
Metolazone Metolazone Iloperidone may decrease the antihypertensive activities of Metolazone.
Clindamycin Injection Clindamycin Injection The metabolism of Iloperidone can be decreased when combined with Clindamycin.
Secobarbital Secobarbital The risk or severity of adverse effects can be increased when Secobarbital is combined with Iloperidone.
Desipramine Desipramine The metabolism of Iloperidone can be decreased when combined with Desipramine.
Amitriptyline Amitriptyline Iloperidone may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Amitriptyline.
Imipramine Imipramine Imipramine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Iloperidone.
Quinidine Quinidine The metabolism of Iloperidone can be decreased when combined with Quinidine.
Procainamide Procainamide The metabolism of Procainamide can be decreased when combined with Iloperidone.
Isoniazid Isoniazid The metabolism of Iloperidone can be decreased when combined with Isoniazid.
Rifampin Rifampin The metabolism of Iloperidone can be increased when combined with Rifampicin.
Disopyramide Disopyramide The risk or severity of QTc prolongation can be increased when Disopyramide is combined with Iloperidone.
Valproic Acid Valproic Acid The metabolism of Iloperidone can be decreased when combined with Valproic acid.
Tamoxifen Tamoxifen The metabolism of Iloperidone can be decreased when combined with Tamoxifen.
Butabarbital Butabarbital The risk or severity of adverse effects can be increased when Butabarbital is combined with Iloperidone.
Methimazole Methimazole The metabolism of Iloperidone can be decreased when combined with Methimazole.
Chlorpropamide Chlorpropamide The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Iloperidone.
Tolbutamide Tolbutamide The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Iloperidone.
Tolazamide Tolazamide The therapeutic efficacy of Tolazamide can be decreased when used in combination with Iloperidone.
Dextromethorphan Dextromethorphan The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Iloperidone.
Cyclobenzaprine Cyclobenzaprine The risk or severity of CNS depression can be increased when Iloperidone is combined with Cyclobenzaprine.
Niacin Niacin The metabolism of Iloperidone can be decreased when combined with Niacin.
Baclofen Baclofen The risk or severity of adverse effects can be increased when Baclofen is combined with Iloperidone.
Doxylamine Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Iloperidone.
Cyproheptadine Cyproheptadine The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Iloperidone.
Clemastine Clemastine The risk or severity of QTc prolongation can be increased when Clemastine is combined with Iloperidone.
Chlorpheniramine Chlorpheniramine The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Iloperidone.
Brompheniramine Brompheniramine The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Iloperidone.
Meclizine Meclizine The risk or severity of adverse effects can be increased when Meclizine is combined with Iloperidone.
Hydrochlorothiazide Hydrochlorothiazide The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Iloperidone.
Dantrolene Dantrolene The risk or severity of adverse effects can be increased when Dantrolene is combined with Iloperidone.
Chlorzoxazone Chlorzoxazone The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Iloperidone.
Carisoprodol Carisoprodol The risk or severity of adverse effects can be increased when Carisoprodol is combined with Iloperidone.
Methocarbamol Methocarbamol The risk or severity of adverse effects can be increased when Methocarbamol is combined with Iloperidone.
Danazol Danazol The metabolism of Iloperidone can be decreased when combined with Danazol.
Disulfiram Disulfiram The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Iloperidone.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The risk or severity of QTc prolongation can be increased when Propranolol is combined with Iloperidone.
Minoxidil Minoxidil Iloperidone may decrease the antihypertensive activities of Minoxidil.
Pseudoephedrine Pseudoephedrine Pseudoephedrine may decrease the sedative and stimulatory activities of Iloperidone.
Nortriptyline Nortriptyline Iloperidone may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Nortriptyline.
Amphotericin B Injection Amphotericin B Injection The metabolism of Iloperidone can be decreased when combined with Amphotericin B.
Nadolol Nadolol Nadolol may increase the orthostatic hypotensive activities of Iloperidone.
Butorphanol Injection Butorphanol Injection The risk or severity of adverse effects can be increased when Butorphanol is combined with Iloperidone.
Nalbuphine Injection Nalbuphine Injection The risk or severity of adverse effects can be increased when Nalbuphine is combined with Iloperidone.
Oxytocin Injection Oxytocin Injection The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Iloperidone.
Trimethobenzamide Trimethobenzamide The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Iloperidone.
Flavoxate Flavoxate Iloperidone may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.
Papaverine Papaverine The risk or severity of QTc prolongation can be increased when Papaverine is combined with Iloperidone.
Fluorouracil Injection Fluorouracil Injection The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Iloperidone.
Colchicine Colchicine The metabolism of Iloperidone can be decreased when combined with Colchicine.
Acetazolamide Acetazolamide The metabolism of Iloperidone can be decreased when combined with Acetazolamide.
Ketoconazole Ketoconazole The metabolism of Iloperidone can be decreased when combined with Ketoconazole.
Pyrantel Pyrantel The risk or severity of adverse effects can be increased when Iloperidone is combined with Pyrantel.
Vincristine Injection Vincristine Injection The metabolism of Iloperidone can be decreased when combined with Vincristine.
Captopril Captopril Iloperidone may decrease the antihypertensive activities of Captopril.
Dipyridamole Dipyridamole The risk or severity of hypotension, dyspepsia, and headache can be increased when Dipyridamole is combined with Iloperidone.
Isoxsuprine Isoxsuprine The therapeutic efficacy of Isoxsuprine can be decreased when used in combination with Iloperidone.
Vinblastine Vinblastine The metabolism of Iloperidone can be decreased when combined with Vinblastine.
Metoprolol Metoprolol The metabolism of Iloperidone can be decreased when combined with Metoprolol.
Hydroxyzine Hydroxyzine The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Iloperidone.
Thiothixene Thiothixene The risk or severity of adverse effects can be increased when Thiothixene is combined with Iloperidone.
Aspirin Aspirin The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Iloperidone.
Salsalate Salsalate The risk or severity of hypertension can be increased when Salsalate is combined with Iloperidone.
Alprazolam Alprazolam The risk or severity of adverse effects can be increased when Alprazolam is combined with Iloperidone.
Temazepam Temazepam The risk or severity of adverse effects can be increased when Temazepam is combined with Iloperidone.
Triazolam Triazolam The risk or severity of adverse effects can be increased when Triazolam is combined with Iloperidone.
Dicyclomine Dicyclomine Iloperidone may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Hyoscyamine Hyoscyamine The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Iloperidone.
Propantheline Propantheline Iloperidone may increase the central nervous system depressant (CNS depressant) activities of Propantheline.
Diltiazem Diltiazem The metabolism of Iloperidone can be decreased when combined with Diltiazem.
Nifedipine Nifedipine The risk or severity of QTc prolongation can be increased when Iloperidone is combined with Nifedipine.
Timolol Timolol The risk or severity of QTc prolongation can be increased when Timolol is combined with Iloperidone.
Verapamil Verapamil The metabolism of Iloperidone can be decreased when combined with Verapamil.
Atenolol Atenolol Atenolol may increase the orthostatic hypotensive activities of Iloperidone.
Pindolol Pindolol Pindolol may increase the orthostatic hypotensive activities of Iloperidone.
Diflunisal Diflunisal The risk or severity of hypertension can be increased when Diflunisal is combined with Iloperidone.
Piroxicam Piroxicam The risk or severity of hypertension can be increased when Piroxicam is combined with Iloperidone.
Etoposide Etoposide The metabolism of Iloperidone can be decreased when combined with Etoposide.
Glyburide Glyburide The metabolism of Iloperidone can be decreased when combined with Glyburide.
Glipizide Glipizide The therapeutic efficacy of Glipizide can be decreased when used in combination with Iloperidone.
Indapamide Indapamide The risk or severity of QTc prolongation can be increased when Indapamide is combined with Iloperidone.
Pentoxifylline Pentoxifylline The risk or severity of hypotension, dyspepsia, and headache can be increased when Pentoxifylline is combined with Iloperidone.
Pentamidine Injection Pentamidine Injection The risk or severity of QTc prolongation can be increased when Pentamidine is combined with Iloperidone.
Labetalol Labetalol Labetalol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Iloperidone.
Leuprolide Injection Leuprolide Injection The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Iloperidone.
Guanabenz Guanabenz The therapeutic efficacy of Guanabenz can be decreased when used in combination with Iloperidone.
Ketoprofen Ketoprofen The risk or severity of hypertension can be increased when Ketoprofen is combined with Iloperidone.
Pimozide Pimozide The metabolism of Iloperidone can be decreased when combined with Pimozide.
Enalapril Enalapril Iloperidone may decrease the antihypertensive activities of Enalapril.
Flurbiprofen Flurbiprofen The risk or severity of hypertension can be increased when Flurbiprofen is combined with Iloperidone.
Amiodarone Amiodarone The metabolism of Iloperidone can be decreased when combined with Amiodarone.
Buspirone Buspirone The risk or severity of serotonin syndrome can be increased when Buspirone is combined with Iloperidone.
Lovastatin Lovastatin The metabolism of Iloperidone can be decreased when combined with Lovastatin.
Ciprofloxacin Ciprofloxacin The metabolism of Iloperidone can be decreased when combined with Ciprofloxacin.
Mesalamine Mesalamine The risk or severity of hypertension can be increased when Mesalazine is combined with Iloperidone.
Diclofenac Diclofenac The risk or severity of hypertension can be increased when Diclofenac is combined with Iloperidone.
Fluoxetine Fluoxetine The serum concentration of Fluoxetine can be increased when it is combined with Iloperidone.
Nimodipine Nimodipine The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Iloperidone.
Clozapine Clozapine The metabolism of Iloperidone can be decreased when combined with Clozapine.
Estazolam Estazolam The risk or severity of adverse effects can be increased when Estazolam is combined with Iloperidone.
Idarubicin Idarubicin The metabolism of Iloperidone can be decreased when combined with Idarubicin.
Ofloxacin Ofloxacin The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Iloperidone.
Didanosine Didanosine Didanosine may increase the neurotoxic activities of Iloperidone.
Clarithromycin Clarithromycin The metabolism of Iloperidone can be decreased when combined with Clarithromycin.
Benazepril Benazepril Iloperidone may decrease the antihypertensive activities of Benazepril.
Etodolac Etodolac The risk or severity of hypertension can be increased when Etodolac is combined with Iloperidone.
Felodipine Felodipine The metabolism of Iloperidone can be decreased when combined with Felodipine.
Fosinopril Fosinopril Iloperidone may decrease the antihypertensive activities of Fosinopril.
Nabumetone Nabumetone The risk or severity of hypertension can be increased when Nabumetone is combined with Iloperidone.
Quinapril Quinapril Iloperidone may decrease the antihypertensive activities of Quinapril.
Ramipril Ramipril Iloperidone may decrease the antihypertensive activities of Ramipril.
Simvastatin Simvastatin The metabolism of Iloperidone can be decreased when combined with Simvastatin.
Amlodipine Amlodipine The risk or severity of hypotension can be increased when Iloperidone is combined with Amlodipine.
Teniposide Injection Teniposide Injection The metabolism of Iloperidone can be decreased when combined with Teniposide.
Itraconazole Itraconazole The metabolism of Iloperidone can be decreased when combined with Itraconazole.
Lisinopril Lisinopril Iloperidone may decrease the antihypertensive activities of Lisinopril.
Oxaprozin Oxaprozin The risk or severity of hypertension can be increased when Oxaprozin is combined with Iloperidone.
Sotalol Sotalol The metabolism of Sotalol can be decreased when combined with Iloperidone.
Bisoprolol Bisoprolol Bisoprolol may increase the orthostatic hypotensive activities of Iloperidone.
Zolpidem Zolpidem Iloperidone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Doxazosin Doxazosin Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Iloperidone.
Terazosin Terazosin Terazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Iloperidone.
Isradipine Isradipine The metabolism of Iloperidone can be decreased when combined with Isradipine.
Omeprazole Omeprazole The metabolism of Iloperidone can be decreased when combined with Omeprazole.
Cisapride Cisapride The metabolism of Iloperidone can be decreased when combined with Cisapride.
Gabapentin Gabapentin The risk or severity of adverse effects can be increased when Gabapentin is combined with Iloperidone.
Fluvastatin Fluvastatin The metabolism of Iloperidone can be decreased when combined with Fluvastatin.
Venlafaxine Venlafaxine The metabolism of Iloperidone can be decreased when combined with Venlafaxine.
Stavudine Stavudine Stavudine may increase the neurotoxic activities of Iloperidone.
Fluvoxamine Fluvoxamine The metabolism of Iloperidone can be decreased when combined with Fluvoxamine.
Nefazodone Nefazodone The metabolism of Iloperidone can be decreased when combined with Nefazodone.
Lamotrigine Lamotrigine The risk or severity of adverse effects can be increased when Lamotrigine is combined with Iloperidone.
Losartan Losartan The metabolism of Iloperidone can be decreased when combined with Losartan.
Tramadol Tramadol The risk or severity of serotonin syndrome can be increased when Tramadol is combined with Iloperidone.
Vinorelbine Injection Vinorelbine Injection The metabolism of Iloperidone can be decreased when combined with Vinorelbine.
Moexipril Moexipril The risk or severity of QTc prolongation can be increased when Moexipril is combined with Iloperidone.
Lansoprazole Lansoprazole The metabolism of Iloperidone can be decreased when combined with Lansoprazole.
Ifosfamide Injection Ifosfamide Injection The metabolism of Iloperidone can be decreased when combined with Ifosfamide.
Nicardipine Nicardipine The metabolism of Iloperidone can be decreased when combined with Nicardipine.
Bupropion Bupropion The metabolism of Iloperidone can be decreased when combined with Bupropion.
Ticlopidine Ticlopidine The metabolism of Iloperidone can be decreased when combined with Ticlopidine.
Saquinavir Saquinavir The metabolism of Iloperidone can be decreased when combined with Saquinavir.
Metformin Metformin The therapeutic efficacy of Metformin can be decreased when used in combination with Iloperidone.
Nisoldipine Nisoldipine The risk or severity of hypotension can be increased when Nisoldipine is combined with Iloperidone.
Riluzole Riluzole The risk or severity of adverse effects can be increased when Riluzole is combined with Iloperidone.
Acarbose Acarbose The therapeutic efficacy of Acarbose can be decreased when used in combination with Iloperidone.
Glimepiride Glimepiride The therapeutic efficacy of Glimepiride can be decreased when used in combination with Iloperidone.
Indinavir Indinavir The metabolism of Iloperidone can be decreased when combined with Indinavir.
Ritonavir Ritonavir The metabolism of Iloperidone can be decreased when combined with Ritonavir.
Docetaxel Injection Docetaxel Injection The metabolism of Iloperidone can be decreased when combined with Docetaxel.
Clomipramine Clomipramine The metabolism of Iloperidone can be decreased when combined with Clomipramine.
Zafirlukast Zafirlukast The metabolism of Iloperidone can be decreased when combined with Zafirlukast.
Mirtazapine Mirtazapine Iloperidone may increase the serotonergic activities of Mirtazapine.
Trandolapril Trandolapril Iloperidone may decrease the antihypertensive activities of Trandolapril.
Topiramate Topiramate The risk or severity of adverse effects can be increased when Topiramate is combined with Iloperidone.
Valsartan Valsartan Iloperidone may decrease the antihypertensive activities of Valsartan.
Insulin Lispro Injection Insulin Lispro Injection The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Iloperidone.
Pramipexole Pramipexole The therapeutic efficacy of Pramipexole can be decreased when used in combination with Iloperidone.
Donepezil Donepezil The risk or severity of adverse effects can be increased when Donepezil is combined with Iloperidone.
Nelfinavir Nelfinavir The metabolism of Iloperidone can be decreased when combined with Nelfinavir.
Azithromycin Azithromycin The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Iloperidone.
Carvedilol Carvedilol Carvedilol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Iloperidone.
Flutamide Flutamide The metabolism of Iloperidone can be decreased when combined with Flutamide.
Selegiline Selegiline The risk or severity of adverse effects can be increased when Selegiline is combined with Iloperidone.
Bicalutamide Bicalutamide The metabolism of Iloperidone can be decreased when combined with Bicalutamide.
Sertraline Sertraline The risk or severity of adverse effects can be increased when Sertraline is combined with Iloperidone.
Propafenone Propafenone The metabolism of Iloperidone can be decreased when combined with Propafenone.
Raloxifene Raloxifene The metabolism of Iloperidone can be decreased when combined with Raloxifene.
Irbesartan Irbesartan The metabolism of Iloperidone can be decreased when combined with Irbesartan.
Tamsulosin Tamsulosin Tamsulosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Iloperidone.
Ropinirole Ropinirole The therapeutic efficacy of Ropinirole can be decreased when used in combination with Iloperidone.
Finasteride Finasteride The metabolism of Iloperidone can be decreased when combined with Finasteride.
Quetiapine Quetiapine Quetiapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Iloperidone.
Cetirizine Cetirizine The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Iloperidone.
Paroxetine Paroxetine The metabolism of Iloperidone can be decreased when combined with Paroxetine.
Tolcapone Tolcapone The therapeutic efficacy of Tolcapone can be decreased when used in combination with Iloperidone.
Citalopram Citalopram The metabolism of Iloperidone can be decreased when combined with Citalopram.
Efavirenz Efavirenz The metabolism of Iloperidone can be decreased when combined with Efavirenz.
Sildenafil Sildenafil The risk or severity of hypotension, dyspepsia, and headache can be increased when Sildenafil is combined with Iloperidone.
Pioglitazone Pioglitazone The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Iloperidone.
Celecoxib Celecoxib The metabolism of Iloperidone can be decreased when combined with Celecoxib.
Rosiglitazone Rosiglitazone The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Iloperidone.
Tolterodine Tolterodine The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Iloperidone.
Thalidomide Thalidomide Iloperidone may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Balsalazide Balsalazide The risk or severity of hypertension can be increased when Balsalazide is combined with Iloperidone.
Nateglinide Nateglinide The therapeutic efficacy of Nateglinide can be decreased when used in combination with Iloperidone.
Galantamine Galantamine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Iloperidone.
Levetiracetam Levetiracetam The risk or severity of adverse effects can be increased when Levetiracetam is combined with Iloperidone.
Rabeprazole Rabeprazole The metabolism of Iloperidone can be decreased when combined with Rabeprazole.
Terbinafine Terbinafine The metabolism of Iloperidone can be decreased when combined with Terbinafine.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists